Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Cyrus Cooper, of the University of Oxford and Southampton, has been appointed as a Deputy Lieutenant of Hampshire.

Professor Cooper, who is Professor of Musculoskeletal Sciences at Oxford and Director of the Medical Research Council Lifecourse Epidemiology Unit at the University of Southampton, will take up the position immediately and support the Lord-Lieutenant in carrying out his functions as HM The Queen’s representative in the county.

Awarded an OBE in January 2015 for services to medical research, Professor Cooper will continue his role at both Oxford and Southampton, leading internationally competitive research in the epidemiology of musculoskeletal disorders, most notably osteoporosis.

Professor Cooper will support the Lord-Lieutenant in carrying out his functions as HM The Queen’s representative in the county of Hampshire. The duties of the Lord-Lieutenant include, among others, arrangement of Royal visits to the county, liaison with local units of the Royal Navy, Army and Royal Air Force, and presentations of awards on behalf of HM The Queen.

Similar stories

Clinical trial finds Azithromycin has no benefit against COVID-19

Main OCTRU

A clinical trial by University of Oxford researchers has confirmed that the antibiotic azithromycin has no clinical benefit in people with moderate COVID-19.

Study reveals the three most important aspects of care for hip fractures

Hip Main OCTRU Research Trauma

Older patients with hip fractures recover better if they receive treatment under the supervision of both a surgeon and a specialist in elderly care; are checked to avoid future falls; and are assessed for memory problems.

Major ERC funding awarded to Professor Michael Dustin

Awards Kennedy Main

Professor Michael Dustin and an international team of collaborators have been awarded a €10M grant from the European Research Council (ERC) to develop a new biotechnology around supramolecular attack particles (SMAPs) engineered to kill cancer cells.

The role of mAbs (neutralising monoclonal antibodies) in the fight against COVID-19

Main Research

Neutralising mAbs, a form of anti-viral medicine, are being explored as an attractive option to treat symptoms of COVID-19 and in some cases prevent infection. But what are the pros and cons of this type of treatment and what should regulators consider before granting approval?

Professor Michael Dustin elected to the National Academy of Sciences

Awards Kennedy Main

Recognised for his outstanding contributions to the field of immunology, Michael becomes the fourth Kennedy professor to be elected to the Academy.

Small mechanical forces in immune cells measured at unprecedented sensitivity

Kennedy Main Research

Oxford researchers have used advanced microscopy techniques to measure previously unseen forces generated by cells during an immune response; a breakthrough for mechanobiology and future advances in health and disease.